You may have to Search all our reviewed books and magazines, click the sign up button below to create a free account.
Cancer touches everybody’s life in one way or another. But most of us know very little about how the disease works, why we treat it the way we do, and the personalities whose dedication got us where we are today. For fifty years, Dr. Vincent T. DeVita Jr. has been one of those key players: he has held just about every major position in the field, and he developed the first successful chemotherapy treatment for Hodgkin’s lymphoma, a breakthrough the American Society of Clinical Oncologists has called the top research advance in half a century of chemotherapy. As one of oncology’s leading figures, DeVita knows what cancer looks like from the lab bench and the bedside. The Death of Cancer...
Completely revised and updated for 2023, the Physicians' Cancer Chemotherapy Drug Manual is an up-to-date guide to the latest information on standard therapy and recent advances in the field. Written by world-class experts in clinical cancer therapeutics, this essential reference provides a complete, easy-to-use catalogue of over 100 drugs and commonly used drug regimens--both on- and off-label--for the treatment of all the major cancers. Key Features: - Includes 9 new agents and 24 new supplemental indications that have all been approved by the FDA within the past year - Updated new indications for previously approved agents - Indications, drug doses and schedules, toxicities, and special considerations for each agent expanded and revised - A specific chapter focused on antiemetic treatment regimens for both acute and delayed nausea/vomiting - Diagrams of drug structures and pathways for many of the agents - A comprehensive discussion of clinical pharmacology, special considerations, indications, and dosages - Covers toxicity and drug-drug interactions - A section on chemotherapy regimens for all major cancers - Provides an overview of the basic principles of cancer drug therapy
"A personal history of the war on cancer, told by the pioneering oncologist who developed the first successful chemotherapy treatment for Hodgkin's lymphoma"--
Written by world-class experts in clinical cancer therapeutics, Physicians’ Cancer Chemotherapy Drug Manual 2021 provides a complete, easy-to-use catalog of over 100 drugs and commonly used drug regimens—both on- and off-label—for the treatment of all the major cancers.
Based on: DeVita, Hellman, and Rosenberg's cancer / editors, Vincent T. DeVita Jr., Theodore S. Lawrence, Steven A. Rosenberg. 9th ed. c2011.
Written by world-class experts in clinical cancer therapeutics, Physicians’ Cancer Chemotherapy Drug Manual 2022 provides a complete, easy-to-use catalog of over 100 drugs and commonly used drug regimens—both on- and off-label—for the treatment of all the major cancers.
The standard-setting text in oncology for 40 years, DeVita, Hellman and Rosenberg’s Cancer: Principles and Practice of Oncology, 12th Edition, provides authoritative guidance and strategies for managing every type of cancer by stage and presentation. Drs. Vincent T. DeVita, Jr., Theodore S. Lawrence, and Steven A. Rosenberg oversee an outstanding team of expert contributing authors who keep you up to date and fully informed in this fast-changing field. This award-winning reference is also continually updated on Health Library and VitalSource platforms for the life of the edition.
Examines molecular biologic techniques including proteomics, genomics, targeted therapies, RNA interference, cDNA arrays, and tissue arrays. This book contains sections discussing bioinformatics and societal issues in oncology, including regulatory issues, telemedicine, and international differences in oncology.
Oncology in Primary Care is for primary care clinicians who need practical and concise information on caring for their patients with cancer. Written in an easy-to-browse format, chapters cover risk factors, prevention, screening, prognosis, and surveillance strategies—valuable information that helps primary care clinicians advise their patients regarding therapeutic and end-of-life decisions and become true partners in the care of their patients with cancer. Each chapter also includes an abundance of figures and tables to help clinicians find quick answers to questions commonly encountered in the primary care setting. Plus, a companion website is available allowing easy accessibility to the content.
None